Published in Vaccine Weekly, February 9th, 2011
Proof of this concept could lead to the development of a vaccine to prevent diabetes in children.
A significant catalyst for the formation of the network, PEVNET*, was the research paper published by researchers from PCMD in collaboration with colleagues from the NHS in Glasgow and the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2011-02-09)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.